British drugmaker AstraZeneca said on Saturday its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of...
from NDTV News - World-news https://ift.tt/3aCYrCE
Oxford Covid Vaccine Less Effective Against South African Variant: Study https://ift.tt/eA8V8J
By -
February 07, 2021
0
Tags:
Post a Comment
0Comments